首頁
KORU MEDICAL SYSTEMS

7月 2026KORU MEDICAL SYSTEMS的市場佔有率分析

Subcutaneous Immunoglobulin infusions give patients flexibility and control of their time, with fewer side effects and no need of painful and repeated vein access.

健康 > 健康 - 其他

域名korumedical.com

成立年份1980

僱員51 - 200

年度營收$25M - $50M

KORU MEDICAL SYSTEMS

KORU MEDICAL SYSTEMS（包含公司地區）

korumedical.com

查看更多網站流量與參與度資訊

KORU MEDICAL SYSTEMS截至 7月 2026 的總收入為 25M - 50M

KORU MEDICAL SYSTEMS 熱門網域產生的總收入

KORU MEDICAL SYSTEMS 熱門網域 3 年內的總收入

KORU MEDICAL SYSTEMS 熱門網域的總收入

korumedical.com25M - 50M

透過銷售情報查看更多內容

KORU MEDICAL SYSTEMS的熱門網域總造訪量

了解KORU MEDICAL SYSTEMS市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

korumedical.com3.5K

透過銷售情報查看更多內容

KORU MEDICAL SYSTEMS的熱門網域平均造訪時長

分析KORU MEDICAL SYSTEMS參與度指標。

過去 3 個月平均造訪時長

子公司細目

korumedical.com00:00:11

透過銷售情報查看更多內容

KORU MEDICAL SYSTEMS的熱門網域平均頁面瀏覽量

了解KORU MEDICAL SYSTEMS如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

korumedical.com1.85

透過銷售情報查看更多內容

KORU MEDICAL SYSTEMS按網域劃分的熱門競爭對手

看起來這裡的數據不足

無可顯示數據

使用的熱門技術KORU MEDICAL SYSTEMS

这些是KORU MEDICAL SYSTEMS顶级域名使用的行业网站技术

付費廣告 (6)

Google Adsense

轉換與分析 (5)

Google Analytics

小工具 (5)

Twemoji

付款與貨幣 (3)

Visa

更多技術

10

檢視所有

新聞與訊號來自KORU MEDICAL SYSTEMS

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞KORU Medical Systems, Inc. attended event 51st Annual Oncology Nursing Society Congress on May 13th '26.KORU Medical Systems presents real world Data on the benefits of the FreedomEDGE Syringe Infusion System in infusion clinics at the 51st Annual Oncology Nursing Society Congress.

新聞KORU Medical Systems, Inc. hires Eric.Eric joins KORU Medical with more than 25 years of leadership experience across research & development, device engineering, drug - device combination product development, supply chain strategy, and end-to-end product lifecycle management.

新聞KORU Medical Systems, Inc. attends event ESID/EHA/SIOPE Focused Symposium 2025.MAHWAH, N.J.-(BUSINESS WIRE)-KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will present its latest research at the ESID/EHA/SIOPE Focused Symposium 2025 in Vienna, Austria, November 18-20.